251 related articles for article (PubMed ID: 24019492)
1. Mechanism for activation of mutated epidermal growth factor receptors in lung cancer.
Red Brewer M; Yun CH; Lai D; Lemmon MA; Eck MJ; Pao W
Proc Natl Acad Sci U S A; 2013 Sep; 110(38):E3595-604. PubMed ID: 24019492
[TBL] [Abstract][Full Text] [Related]
2. Her4 and Her2/neu tyrosine kinase domains dimerize and activate in a reconstituted in vitro system.
Monsey J; Shen W; Schlesinger P; Bose R
J Biol Chem; 2010 Mar; 285(10):7035-44. PubMed ID: 20022944
[TBL] [Abstract][Full Text] [Related]
3. Activity and cellular localization of an oncogenic glioblastoma multiforme-associated EGF receptor mutant possessing a duplicated kinase domain.
Ozer BH; Wiepz GJ; Bertics PJ
Oncogene; 2010 Feb; 29(6):855-64. PubMed ID: 19915609
[TBL] [Abstract][Full Text] [Related]
4. Conformational Insight on WT- and Mutated-EGFR Receptor Activation and Inhibition by Epigallocatechin-3-Gallate: Over a Rational Basis for the Design of Selective Non-Small-Cell Lung Anticancer Agents.
Minnelli C; Laudadio E; Mobbili G; Galeazzi R
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32138321
[TBL] [Abstract][Full Text] [Related]
5. The juxtamembrane region of the EGF receptor functions as an activation domain.
Red Brewer M; Choi SH; Alvarado D; Moravcevic K; Pozzi A; Lemmon MA; Carpenter G
Mol Cell; 2009 Jun; 34(6):641-51. PubMed ID: 19560417
[TBL] [Abstract][Full Text] [Related]
6. Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors.
Jia Y; Yun CH; Park E; Ercan D; Manuia M; Juarez J; Xu C; Rhee K; Chen T; Zhang H; Palakurthi S; Jang J; Lelais G; DiDonato M; Bursulaya B; Michellys PY; Epple R; Marsilje TH; McNeill M; Lu W; Harris J; Bender S; Wong KK; Jänne PA; Eck MJ
Nature; 2016 Jun; 534(7605):129-32. PubMed ID: 27251290
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic insights into the activation of oncogenic forms of EGF receptor.
Wang Z; Longo PA; Tarrant MK; Kim K; Head S; Leahy DJ; Cole PA
Nat Struct Mol Biol; 2011 Nov; 18(12):1388-93. PubMed ID: 22101934
[TBL] [Abstract][Full Text] [Related]
8. Cetuximab response of lung cancer-derived EGF receptor mutants is associated with asymmetric dimerization.
Cho J; Chen L; Sangji N; Okabe T; Yonesaka K; Francis JM; Flavin RJ; Johnson W; Kwon J; Yu S; Greulich H; Johnson BE; Eck MJ; Jänne PA; Wong KK; Meyerson M
Cancer Res; 2013 Nov; 73(22):6770-9. PubMed ID: 24063894
[TBL] [Abstract][Full Text] [Related]
9. EGFR over-expression in non-small cell lung cancers harboring EGFR mutations is associated with marked down-regulation of CD82.
Yang CH; Chou HC; Fu YN; Yeh CL; Cheng HW; Chang IC; Liu KJ; Chang GC; Tsai TF; Tsai SF; Liu HP; Wu YC; Chen YT; Huang SF; Chen YR
Biochim Biophys Acta; 2015 Jul; 1852(7):1540-9. PubMed ID: 25912735
[TBL] [Abstract][Full Text] [Related]
10. Molecular dynamics analysis of conserved hydrophobic and hydrophilic bond-interaction networks in ErbB family kinases.
Shih AJ; Telesco SE; Choi SH; Lemmon MA; Radhakrishnan R
Biochem J; 2011 Jun; 436(2):241-51. PubMed ID: 21426301
[TBL] [Abstract][Full Text] [Related]
11. Her2 activation mechanism reflects evolutionary preservation of asymmetric ectodomain dimers in the human EGFR family.
Arkhipov A; Shan Y; Kim ET; Dror RO; Shaw DE
Elife; 2013 Jul; 2():e00708. PubMed ID: 23878723
[TBL] [Abstract][Full Text] [Related]
12. Basic Amino Acids Within the Juxtamembrane Domain of the Epidermal Growth Factor Receptor Regulate Receptor Dimerization and Auto-phosphorylation.
Mohr JD; Wagenknecht-Wiesner A; Holowka DA; Baird BA
Protein J; 2020 Oct; 39(5):476-486. PubMed ID: 33211253
[TBL] [Abstract][Full Text] [Related]
13. A single ligand is sufficient to activate EGFR dimers.
Liu P; Cleveland TE; Bouyain S; Byrne PO; Longo PA; Leahy DJ
Proc Natl Acad Sci U S A; 2012 Jul; 109(27):10861-6. PubMed ID: 22699492
[TBL] [Abstract][Full Text] [Related]
14. Ligand-induced dimer-tetramer transition during the activation of the cell surface epidermal growth factor receptor-A multidimensional microscopy analysis.
Clayton AH; Walker F; Orchard SG; Henderson C; Fuchs D; Rothacker J; Nice EC; Burgess AW
J Biol Chem; 2005 Aug; 280(34):30392-9. PubMed ID: 15994331
[TBL] [Abstract][Full Text] [Related]
15. Structural analysis of the EGFR/HER3 heterodimer reveals the molecular basis for activating HER3 mutations.
Littlefield P; Liu L; Mysore V; Shan Y; Shaw DE; Jura N
Sci Signal; 2014 Dec; 7(354):ra114. PubMed ID: 25468994
[TBL] [Abstract][Full Text] [Related]
16. Cigarette smoke induces aberrant EGF receptor activation that mediates lung cancer development and resistance to tyrosine kinase inhibitors.
Filosto S; Becker CR; Goldkorn T
Mol Cancer Ther; 2012 Apr; 11(4):795-804. PubMed ID: 22302097
[TBL] [Abstract][Full Text] [Related]
17. Allosteric modulation by protein kinase Cε leads to modified responses of EGF receptor towards tyrosine kinase inhibitors.
Weisheit S; Liebmann C
Cell Signal; 2012 Feb; 24(2):422-434. PubMed ID: 21964064
[TBL] [Abstract][Full Text] [Related]
18. The induction of MIG6 under hypoxic conditions is critical for dormancy in primary cultured lung cancer cells with activating EGFR mutations.
Endo H; Okami J; Okuyama H; Nishizawa Y; Imamura F; Inoue M
Oncogene; 2017 May; 36(20):2824-2834. PubMed ID: 27893711
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor juxtamembrane region regulates allosteric tyrosine kinase activation.
Thiel KW; Carpenter G
Proc Natl Acad Sci U S A; 2007 Dec; 104(49):19238-43. PubMed ID: 18042729
[TBL] [Abstract][Full Text] [Related]
20. Structural analysis of the mechanism of inhibition and allosteric activation of the kinase domain of HER2 protein.
Aertgeerts K; Skene R; Yano J; Sang BC; Zou H; Snell G; Jennings A; Iwamoto K; Habuka N; Hirokawa A; Ishikawa T; Tanaka T; Miki H; Ohta Y; Sogabe S
J Biol Chem; 2011 May; 286(21):18756-65. PubMed ID: 21454582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
